Affymax Inc (OTCQB:AFFY.PK)
| 1.07 Data as of 3:59pm ET |  0.00 / 0.00%Today’s Change | 0.78 Today|||52-Week Range 27.74 | -94.37% Year-to-Date |
Latest AFFY.PK News | Press Releases
| Questcor Pop: Acquisition Trumps Competition Jun 13 / MotleyFool.com |
Today’s Trading
| Previous close | 1.07 |
| Today’s open | 1.08 |
| Day’s range | 1.02 - 1.08 |
| Volume | 640,608 |
| Average volume (3 months) | 6,924,169 |
| Market cap | -- |
| Dividend yield | -- |
Data as of 3:59pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -39.67% |
| Earnings growth (this year) | +40.08% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +97.76% |
| P/E ratio | NM |
| Price/Sales | 7.31 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 7, 2013 |
| EPS forecast (this quarter) | -$0.37 |
| Annual revenue (last year) | $94.4M |
| Annual profit (last year) | -$93.4M |
| Net profit margin | -98.98% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Richard M. Brenner |
Chief Financial Officer Mark G. Thompson, MBA |
Corporate headquarters Palo Alto, California |
Forecasts
